Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
04/2014
04/22/2014US8703097 Compositions and method for multimodal imaging
04/22/2014US8703096 Beta-amyloid PET imaging agents
04/22/2014CA2574496C Methods for diagnosis using anti-cytokine receptor antibodies
04/17/2014WO2014057957A1 Steroid compound, and medicine comprising same
04/17/2014WO2014057291A1 Compounds and their synthesis
04/17/2014US20140107041 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
04/17/2014US20140105820 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
04/17/2014US20140105819 In Vivo Copper-Free Click Chemistry for Delivery of Therapeutic and/or Diagnostic Agents
04/17/2014US20140105818 Novel Vesicles and Nanostructures from Recombinant Proteins
04/17/2014DE202012012922U1 Multifunktionale anorganische Nanopartikel auf Basis von Calciumfluorid für die multimodale Bildgebung, deren Herstellung und Anwendung Multifunctional inorganic nanoparticles based on calcium fluoride for the multimodal imaging, their preparation and application
04/16/2014EP2717925A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
04/16/2014EP2717920A2 Activatable nanoprobes for intracellular drug delivery
04/16/2014EP2717857A1 Method for the synthesis of porphyrin-phospholipid conjugates
04/16/2014CN103732260A Radiolabelled phenylimidazole-based ligands
04/16/2014CN103732259A Extracellular targeted drug conjugates
04/16/2014CN103724207A Hydroxyphenyl benzyl ether derivative as well as preparation method and application thereof
04/16/2014CN102977189B Polypeptide combined with FAP (Fibroblast Activation Protein)
04/16/2014CN101967148B Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of p-benzenesulfonyloxy and preparation and application
04/16/2014CN101723848B Novel 18F labeled m-nitro benzoyl amino acids, preparation method and application thereof in tumor imaging
04/15/2014US8697712 Presentation of an antiviral pharmaceutical composition
04/15/2014US8697032 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
04/15/2014US8697031 Dual function polymer micelles
04/15/2014US8697030 Particulate materials for radiotherapy and diagnostics
04/15/2014US8697029 Modulated physical and chemical sensors
04/15/2014CA2427643C Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
04/15/2014CA2328414C Methods for detecting and inhibiting angiogenesis
04/10/2014WO2014054884A1 Composition for hyperthermia comprising sensitization material
04/10/2014WO2014004664A3 Treatment of meningiomas using phenylbenzothiazole, stilbene, biphenylalkyne, or pyridine derivatives
04/10/2014WO2012009666A3 Synthesis of 2'-deoxy-2'-[18f]fluoro-5-methyl-1-b-d-arabinofuranosyluracil (18f-fmau)
04/10/2014US20140100377 Novel fluorine-18 labeled rhodamine derivatives for imaging with positron emission tomography
04/10/2014US20140100172 Cancer Imaging and Treatment
04/10/2014US20140099305 Compositions and methods for cancer immunotherapy
04/10/2014US20140099262 Isotopically labeled cdp-choline and uses thereof
04/10/2014US20140099259 Tumor-specific recognition molecules
04/10/2014US20140099256 Radioactive luminescent nanoparticle compositions
04/10/2014US20140099255 Polymer based radionuclide containing particulate material
04/10/2014DE102012019714A1 Producing metallic labeled compounds, involves providing first solution from first solvent comprising water and first non-aqueous solvent, and first acid and first metal dissolved in solvent
04/09/2014EP2716641A1 Novel compound having affinity for amyloid
04/09/2014EP2714098A1 Radiolabelled glutaminyl cyclase inhibitors
04/09/2014EP2714091A2 Modular transport platform for targeted delivery of therapeutic agents
04/09/2014CN103705948A Source-core carrier for radioactive particles, and preparation process thereof
04/08/2014US8691949 Peptide having anti-diabetic activity and use thereof
04/08/2014US8691943 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa
04/08/2014US8691280 Microsphere comprising an organic lanthanide metal complex
04/08/2014US8691255 Method of producing high alcohol content foaming compositions with silicone-based surfactants
04/08/2014US8691186 Imaging infection with compounds that bind to thymidine kinase
04/08/2014US8691185 Benzothiazole derivative compounds, compositions and uses
04/08/2014US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
04/08/2014US8691183 Means for the detection and treatment of prostate cells
04/08/2014CA2624794C Automated radiolabelling method
04/03/2014WO2014052471A1 Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer
04/03/2014WO2014049274A1 Novel compounds comprising iodised or fluorinated dendrimeric groups, methods for preparing same and uses thereof
04/03/2014WO2014048568A1 Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma
04/03/2014WO2014048060A1 Anti-inflammatory drug against cancer and aids with radiotherapy and preparation method thereof
04/03/2014US20140093451 Coupled identification and treatment of cancer
04/03/2014US20140093450 Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene
04/02/2014EP2712631A1 Radiopharmaceutical products for diagnosis and therapy of renal carcinoma
04/02/2014EP2712627A2 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
04/02/2014CN103690972A 18F-labeled quinazoline type EGFR (epidermal growth factor receptor) positron tracer, as well as preparation method and application thereof
04/01/2014US8685962 Compositions, articles and methods comprising TSPO ligands for preventing or reducing tobacco-associated damage
04/01/2014US8685705 Desmosterol-producing yeast strains and uses thereof
04/01/2014US8685422 High alcohol content foaming compositions with silicone-based surfactants
04/01/2014US8685369 Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof
04/01/2014US8685368 Polyamides for nucleic acid delivery
04/01/2014US8685367 Inherently radiopaque polymeric products for embolotherapy
04/01/2014CA2619941C F-18 peptides for pre targeted positron emission tomography imaging
04/01/2014CA2567478C Labelled adrenomedullin derivatives and their use for imaging and therapy
03/2014
03/27/2014WO2014045306A2 F-18 radiolabeled compounds for diagnosing and monitoring kidney function
03/27/2014WO2011031919A3 Non-radioactive phospholipid compounds, compositions, and methods of use
03/27/2014US20140088408 Phage antibodies to radiation-inducible neoantigens
03/27/2014US20140088306 Radioactive fluorine-labeled quinoxaline compound
03/27/2014US20140086994 Synthesis of Small Particles
03/27/2014US20140086837 F-18 radiolabeled compounds for diagnosing and monitoring kidney function
03/27/2014US20140086834 New i-arylpiperazinic ligands of 5-ht7 receptor and use thereof
03/27/2014US20140086833 Non-invasive diagnostic agents and methods of diagnosing infectious disease
03/27/2014US20140086831 Single Wall Nanotube Constructs and Uses Thereof
03/27/2014US20140086830 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
03/27/2014US20140086829 Recombinant Antibodies to the Vascular Endothelial Growth Factor (VEGF) which are Obtained by Means of Mutagenesis of Variable Regions
03/27/2014US20140086828 Modified gold nanoparticles for therapy
03/27/2014US20140086827 Serum S100B And Uses Thereof
03/26/2014EP2711026A1 Radioactive fluorine-labeled quinoxaline compound
03/26/2014EP2710027A1 Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents
03/26/2014EP2535358A9 Radioactive metal-labeled anti-cadherin antibody
03/26/2014CN1901795B Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
03/26/2014CN103687864A Bifunctional phosphonate chelating agents
03/26/2014CN103687854A Carbonic anhydrase targeting agents and methods of using same
03/26/2014CN103687627A Radiolabelled octreotate analogues as pet tracers
03/26/2014CN103656694A 18F-labelled quinazolines irreversible EGFR (epidermal growth factor receptor) positive electron tracer agent, as well as preparation method and application thereof
03/26/2014CN103656693A 18F labeled quinazoline class EGFR (Epidermal Growth Factor Receptor) positron tracer agent and preparation method and application thereof
03/26/2014CN103656692A Nano targeted or ordinary anticancer medicament with radiotherapy function and preparation method thereof
03/26/2014CN102432529B Preparation method of styryl pyridine disulfide dinitrogen derivative
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014US8679516 High alcohol content foaming compositions with silicone-based surfactants
03/25/2014US8679455 Radiolabelling methods
03/25/2014US8679454 Particle immobilized coatings and uses thereof
03/25/2014US8679453 Contrast agents
03/25/2014US8679452 Miniaturized liquid surface reactions using nanomolar amounts of concentrated [11C]carbon dioxide in a stationary gas-phase
03/25/2014CA2825497A1 Radioactive fluorine-labeled quinoxaline compound
03/25/2014CA2753899C Polyalkylene glycol with moiety for conjugating biologically active compounds
03/25/2014CA2445826C Treatment and diagnosis of macrophage mediated disease
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 243